2017 annual financial data

Alnylam Pharmaceuticals 2017 Financial results

Direct answer

Revenue was 89.91M USD.

Operating income was -500.09M USD and net income was -490.87M USD.
Operating cash flow was -382.79M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
89.91M USD
Operating income
-500.09M USD
Net income
-490.87M USD
Operating cash flow
-382.79M USD